U. Theuretzbacher, K. Outterson, A. Engel, and A. Karlén, The global preclinical antibacterial pipeline, Nat Rev Microbiol, 2019.

-. Carb, Combating antibiotic-resistant bacteria, 2019.

E. Tacconelli, A. Peschel, and I. B. Autenrieth, Translational research strategy: an essential approach to fight the spread of antimicrobial resistance, J Antimicrob Chemother, vol.69, pp.2889-91, 2014.

, Comité interministériel pour la santé. Maîtriser la résistance bactérienne aux antibiotiques, 2016.

V. A. Schweitzer, I. Van-heijl, C. H. Van-werkhoven, J. Islam, and K. D. Hendriks-spoor,

J. Bielicki, The quality of studies evaluating antimicrobial stewardship interventions: a systematic review, Clin Microbiol Infect, vol.25, pp.555-61, 2019.

V. Donisi, M. Sibani, E. Carrara, D. Piccolo, L. Rimondini et al.,

, Emotional, cognitive and social factors of antimicrobial prescribing: can antimicrobial stewardship intervention be effective without addressing psycho-social factors?, J Antimicrob Chemother, vol.74, issue.10, pp.2844-2851, 2019.

V. A. Schweitzer, C. H. Van-werkhoven, R. Baño, J. Bielicki, J. Harbarth et al.,

M. Hulscher, Optimizing design of research to evaluate antibiotic stewardship interventions: consensus recommendations of a multinational working group, Clin Microbiol Infect, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02297589

E. Tacconelli, M. A. Cataldo, M. Paul, L. Leibovici, J. Kluytmans et al.,

. Strobe-ams, recommendations to optimise reporting of epidemiological studies on antimicrobial resistance and informing improvement in antimicrobial stewardship, vol.6, p.10134, 2016.

,

, data/ecdc-efsa-and-ema-joint-scientific-opinion-list-outcome-indicators-regards, 2019.

L. Watier, P. Cavalié, B. Coignard, and C. Brun-buisson, Comparing antibiotic consumption between two European countries: are packages an adequate surrogate for prescriptions?, Euro Surveill, vol.22, issue.46, 2017.

, World Health Organisation. AWaRe policy brief, 2019.

C. Vandenbroucke-grauls, G. Kahlmeter, and J. Kluytmans,

M. Bergh, D. L. Monnet, and G. S. Simonsen, The proposed Drug Resistance Index (DRI) is not a good measure of antibiotic effectiveness in relation to drug resistance, BMJ Glob Health, vol.4, p.1838, 2019.

C. Oliveira-hashiguchi, T. , A. Ouakrim, D. Padget, M. Cassini et al.,

, Resistance proportions for eight priority antibiotic-bacterium combinations in OECD, EU/EEA and G20 countries 2000 to 2030: a modelling study, Euro Surveill, issue.20, 2019.

A. Versporten, I. C. Gyssens, C. Pulcini, A. A. Monnier, J. Schouten et al.,

, Metrics to assess the quantity of antibiotic use in the outpatient setting: a systematic review followed by an international multidisciplinary consensus procedure, J Antimicrob Chemother, vol.73, issue.suppl_6, pp.59-66, 2018.

L. Maréchal, M. Tebano, G. Monnier, A. A. Adriaenssens, N. Gyssens et al.,

, Quality indicators assessing antibiotic use in the outpatient setting: a systematic review followed by an international multidisciplinary consensus procedure, J Antimicrob Chemother, vol.73, issue.suppl_6, pp.40-49, 2018.

A. A. Monnier, J. Schouten, L. Maréchal, M. Tebano, G. Pulcini et al., Quality indicators for responsible antibiotic use in the inpatient setting: a systematic review followed by an international multidisciplinary consensus procedure, J Antimicrob Chemother, vol.73, issue.suppl_6, pp.30-39, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02361025

S. Benic, M. Milanic, R. Monnier, A. A. Gyssens, and I. C. ,

A. , Metrics for quantifying antibiotic use in the hospital setting: results from a systematic review and international multidisciplinary consensus procedure, J Antimicrob Chemother, vol.73, issue.suppl_6, pp.50-58, 2018.

B. Rump, A. Timen, M. Verweij, and M. Hulscher, Experiences of carriers of multidrugresistant organisms: a systematic review, Clin Microbiol Infect, vol.25, pp.274-283, 2019.

A. B. Drive and . Report, Revitalizing the antibiotic pipeline, vol.2, 2018.

, World Health Organisation. IACG discussion paper. Antimicrobial resistance: invest in innovation and research, and boost R&D and access, 2018.

S. Lanini, J. Ioannidis, F. Vairo, M. Pletschette, G. Portella et al., Noninferiority versus superiority trial design for new antibiotics in an era of high antimicrobial resistance: the case for post-marketing, adaptive randomised controlled trials, Lancet Infect Dis, vol.pii, pp.30284-30285, 2019.

S. A. Kraemer, A. Ramachandran, and G. G. Perron, Antibiotic pollution in the environment: from microbial ecology to public policy. Microorganisms, vol.7, 2019.

F. Baquero, T. M. Coque, and F. De-la-cruz, Ecology and evolution as targets: the need for novel eco-evo drugs and strategies to fight antibiotic resistance, Antimicrob Agents Chemother, vol.55, pp.3649-60, 2011.

M. Jacobs, N. Grégoire, W. Couet, and J. B. Bulitta, Distinguishing antimicrobial models with different resistance mechanisms via population pharmacodynamic modeling, PLoS Comput Biol, vol.12, p.1004782, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-02141647

J. Berthuin, M. Miras, and F. Bpi, La résistance aux antibiotiques. Un enjeu de santé publique et économique, 2018.

. Folkhalsomyndigheten, Public Health Agency of Sweden. Availability of antibiotics, 2019.

, Department of Health and Social Care. UK government. Development of new antibiotics encouraged with new pharmaceutical payment system, 2019.

. Combacte, CLIN-Net maintains an up-to-date portfolio of clinical trial sites across

, This maximizes the efficiency of site selection and study performance for studies related to antimicrobial resistance, Europe, 2019.

. Infectiologie and . Renarci, Réseau national de recherche clinique en infectiologie, 2019.

. Crics-triggersep, Clinical research in intensive care and sepsis. Trial group for global evaluation and research in sepsis. F-Crin network, 2019.